Filing Flows › Si-Bone (SIBN) › Q3 2026 › vs Q3 2025
Si-Bone (SIBN) Q3 2026 vs Q3 2025 (year over year)
Si-Bone's revenue rose $7.0M (+14%) from $48.7M in Q3 2025 to $55.7M in Q3 2026.
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $55.7M | $48.7M | $7.0M | +14% |
| Other income, net | $731K | $817K | −$86K | -11% |
| Net loss | $3.6M | $4.6M | −$946K | -21% |
| Costs & expenses | $60.1M | $54.0M | $6.0M | +11% |
| Operating costs | $60.1M | $54.0M | $6.0M | +11% |
| Cost of revenue | $11.5M | $9.8M | $1.7M | +18% |
| Research & development | $4.6M | $4.2M | $320K | +8% |
| Sales & marketing | $33.9M | $30.0M | $3.9M | +13% |
| General & admin | $10.1M | $10.0M | $75K | +0.7% |
| Operating cash sources | $9.6M | $6.9M | $2.7M | +39% |
| Depreciation & amortization | $1.7M | $1.5M | $208K | +14% |
| Share-based compensation | $5.7M | $6.2M | −$513K | -8% |
| Working capital & other | $2.2M | −$811K | $3.0M | — |
| Net loss absorbed | $3.6M | $4.6M | −$946K | -21% |
| Operating cash flow | $5.9M | $2.3M | $3.6M | +154% |
| Capital expenditures | $6.4M | $3.0M | $3.4M | +115% |
| Negative free cash flow (OCF − capex) | $427K | $620K | −$193K | -31% |
Questions
How much did Si-Bone's revenue grow year over year in Q3 2026?
Si-Bone's revenue rose $7.0M (+14%) from $48.7M in Q3 2025 to $55.7M in Q3 2026.